2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole

C16H22N2O2S — CID 129488908

IUPAC2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole
SMILESC[C@H](c1ccsc1)c1nnc([C@H]2CCO[C@@H]2C(C)(C)C)o1
InChIInChI=1S/C16H22N2O2S/c1-10(11-6-8-21-9-11)14-17-18-15(20-14)12-5-7-19-13(12)16(2,3)4/h6,8-10,12-13H,5,7H2,1-4H3/t10-,12+,13+/m1/s1
InChIKeyXHKOZZZRKILHLU-WXHSDQCUSA-N
MW306.43 g/mol
LogP4.20
Rot. Bonds3

About 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole

2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole (PubChem CID 129488908) has the molecular formula C16H22N2O2S and a molecular weight of 306.43 g/mol. Its IUPAC name is 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole
PubChem CID129488908
Molecular FormulaC16H22N2O2S
Molecular Weight306.43 g/mol
Exact Mass306.14
IUPAC Name2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole
SMILESC[C@H](c1ccsc1)c1nnc([C@H]2CCO[C@@H]2C(C)(C)C)o1
InChIInChI=1S/C16H22N2O2S/c1-10(11-6-8-21-9-11)14-17-18-15(20-14)12-5-7-19-13(12)16(2,3)4/h6,8-10,12-13H,5,7H2,1-4H3/t10-,12+,13+/m1/s1
InChIKeyXHKOZZZRKILHLU-WXHSDQCUSA-N
XLogP4.20
TPSA48.15 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500306.43
LogP ≤ 54.20
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(Oxolan-3-yl)-5-(2-thiophen-2-ylpropan-2-yl)-1,3,4-oxadiazole
CID 120431256
2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-(1-thiophen-2-ylethyl)-1,3,4-oxadiazole
CID 120431355
2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-(1-thiophen-3-ylethyl)-1,3,4-oxadiazole
CID 120431376
2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1S)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole
CID 129488907
2-[(3R)-oxolan-3-yl]-5-(2-thiophen-2-ylpropan-2-yl)-1,3,4-oxadiazole
CID 129489073
2-[(3S)-oxolan-3-yl]-5-(2-thiophen-2-ylpropan-2-yl)-1,3,4-oxadiazole
CID 129489074
2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-2-ylethyl]-1,3,4-oxadiazole
CID 129490083
2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1S)-1-thiophen-2-ylethyl]-1,3,4-oxadiazole
CID 129490084

Frequently Asked Questions

What is the IUPAC name of 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole?
The IUPAC name of 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole (CID 129488908) is 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole?
The canonical SMILES for 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole is C[C@H](c1ccsc1)c1nnc([C@H]2CCO[C@@H]2C(C)(C)C)o1.
What is the InChIKey of 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole?
The InChIKey is XHKOZZZRKILHLU-WXHSDQCUSA-N. The full InChI is InChI=1S/C16H22N2O2S/c1-10(11-6-8-21-9-11)14-17-18-15(20-14)12-5-7-19-13(12)16(2,3)4/h6,8-10,12-13H,5,7H2,1-4H3/t10-,12+,13+/m1/s1.
What are the key properties of 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole?
2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole has a molecular weight of 306.43 g/mol, XLogP of 4.20, 3 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2S,3S)-2-tert-butyloxolan-3-yl]-5-[(1R)-1-thiophen-3-ylethyl]-1,3,4-oxadiazole is sourced from PubChem (CID 129488908), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).